Scil Technology Receives Renewal of
GMP Certification for its analytical and Bioassay Laboratories
MARTINSRIED, Germany, December 9, 2004 – Scil
Technology, a biopharmaceutical company focused on the development
of dental and orthopaedic tissue regeneration products, today
announced that it has received notification of a renewal of
its GMP certification from the German health authorities.
Scil Technology has received the renewed license for the analytical
and Bioassay Laboratories of the Pharmaceutical Quality unit.
The basis for this includes both Scil Technology’s development
activities in the area of tissue regeneration products and
the Scil Biopharma Services service provision for major partners
in the field of CMC development of new biotechnological
and biosimilar products.
Dr Irina Staatz-Granzer, Managing Director of Scil Technology,
commented:
“Scil Technology has the highest standards of laboratory practice in accordance
with GMP and WHO rules and we plan to continue this record of excellence in
our future development efforts.”
About Scil Technology GmbH
Scil Technology is a private biopharmaceutical development
company focused on dental and orthopaedic tissue regeneration
with a particular emphasis on bone and cartilage repair. The
Company’s lead therapeutic candidates are based on recombinant,
highly specific human growth factors. These are combined with
biodegradable biomaterials to generate local application forms.
Scil Technology’s pipeline for dentistry includes products
that are targeted at periodontal disease, dental implantology
and maxillofacial surgery. Orthopaedic products are developed
for spinal fusion, traumatic lesions of bone and cartilage
tissue and osteoarthritis. Scil Technology has emerged
from the Scil Group and is located in the biotechnology cluster
in Martinsried, Germany.
For more information please visit: http://www.scil.com
Contacts
Media relations:
Sue Charles, MA, MBA, CEO
Northbank Communications
t : +44 (0) 20 7886 8152
e: s.charles@northbankcommunications.com
Douglas Pretsell, Ph.D., Senior Account Manager
Northbank Communications
t : +44 (0) 20 7886 8158
e: d.pretsell@northbankcommunications.com
At Scil Technology:
Dr Irina Staatz-Granzer, Managing Director
Scil Technology GmbH
t: +49 (0)89 85651824
e: irina.staatz@scil.com
|
